The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

被引：0

作者：

Akito Nozaki

Masanori Atsukawa

Chisa Kondo

Hidenori Toyoda

Makoto Chuma

Makoto Nakamuta

Haruki Uojima

Koichi Takaguchi

Hiroki Ikeda

Tsunamasa Watanabe

Shintaro Ogawa

Norio Itokawa

Taeang Arai

Atsushi Hiraoka

Toru Asano

Shinichi Fujioka

Tadashi Ikegami

Toshihide Shima

Chikara Ogawa

Takehiro Akahane

Noritomo Shimada

Shinya Fukunishi

Hiroshi Abe

Akihito Tsubota

Takuya Genda

Hironao Okubo

Shigeru Mikami

Asahiro Morishita

Akio Moriya

Joji Tani

Yoshihiko Tachi

Naoki Hotta

Toru Ishikawa

Takeshi Okanoue

Yasuhito Tanaka

Takashi Kumada

Katsuhiko Iwakiri

Shin Maeda

机构：

[1] Yokohama City University Medical Center,Gastroenterological Center

[2] Nippon Medical School,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[3] Ogaki Municipal Hospital,Department of Gastroenterology

[4] National Hospital Organization Kyushu Medical Center,Department of Gastroenterology, Internal Medicine

[5] Kitasato University School of Medicine,Department of Hepatology

[6] Kagawa Prefectural Central Hospital,Department of Internal Medicine

[7] St. Marianna University School of Medicine,Department of Virology and Liver Unit

[8] Nagoya City University,Division of Gastroenterology, Department of Internal Medicine

[9] Graduate School of Medical Sciences,Division of Gastroenterology, Department of Internal Medicine

[10] Nippon Medical School Chiba Hokusoh Hospital,Gastroenterology Center

[11] Nippon Medical School Musashikosugi Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[12] Ehime Prefectural Central Hospital,Department of Gastroenterology

[13] Tokyo Metropolitan Bokutoh Hospital,Department of Gastroenterology and Hepatology

[14] Okayama Saiseikai General Hospital,Department of Gastroenterology and Hepatology

[15] Tokyo Medical University Ibaraki Medical Center,Department of Gastroenterology

[16] Saiseikai Suita Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[17] Takamatsu Red Cross Hospital,Second Department of Internal Medicine

[18] Japanese Red Cross Ishinomaki Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[19] Otakanomori Hospital,Core Research Facilities for Basic Science

[20] Osaka Medical College,Department of Gastroenterology

[21] Shinmatsudo Central General Hospital,Department of Gastroenterology

[22] The Jikei University School of Medicine,Division of Gastroenterology, Department of Internal Medicine

[23] Juntendo Shizuoka University Hospital,Department of Gastroenterology

[24] Juntendo Nerima University Hospital,Department of Gastroenterology

[25] Kikkoman General Hospital,Department of Internal Medicine

[26] Kagawa University Graduate School of Medicine,Division of Hepatology, Department of Internal Medicine

[27] Mitoyo General Hospital,Department of Hepatology

[28] Yashima General Hospital,Department of Gastroenterology

[29] Bantane Hospital,undefined

[30] Fujita Health University School of Medicine,undefined

[31] Masuko Memorial Hospital,undefined

[32] Saiseikai Niigata Daini Hospital,undefined

[33] Yokohama City University Graduate School of Medicine,undefined

来源：

Hepatology International | 2020年 / 14卷

关键词：

Glecaprevir; Pibrentasvir; Chronic hepatitis C; Refractory factors; Multicenter study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：225 / 238

页数：13

共 50 条

[31] Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis [J].

Back, David ;

Belperio, Pamela ;

Bondin, Mark ;

Negro, Francesco ;

Talal, Andrew H. ;

Park, Caroline ;

Zhang, ZhenZhen ;

Pinsky, Brett ;

Crown, Eric ;

Mensa, Federico J. ;

Marra, Fiona .

JOURNAL OF VIRAL HEPATITIS, 2019, 26 (08) :951-960

[32] Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older [J].

Komaki, Yuri ;

Ozono, Yoshinori ;

Nakamura, Kenichi ;

Iwakiri, Hisayoshi ;

Hasuike, Satoru ;

Sueta, Mitsue ;

Miike, Tadashi ;

Yamamoto, Shojiro ;

Uto, Hirofumi ;

Kusumoto, Kazunori ;

Ochiai, Toshimasa ;

Kato, Junya ;

Komada, Naoto ;

Kuroki, Kazuo ;

Eto, Toshiharu ;

Shigehira, Masafumi ;

Hirono, Shuichi ;

Nagata, Kenji ;

Kawakami, Hiroshi .

BMC GASTROENTEROLOGY, 2022, 22 (01)

[33] Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study [J].

Kang, Yeo Wool ;

Baek, Yang Hyun ;

Lee, Sung Wook ;

Park, Sung-Jae ;

Yoon, Jun Sik ;

Yoon, Ki Tae ;

Hong, Youngmi ;

Heo, Nae-Yun ;

Seo, Kwang Il ;

Lee, Sang Soo ;

Cho, Hyun Chin ;

Shin, Jung Woo .

JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (21)

[34] Efficacy and safety of glecaprevir/pibrentasvir in patients with hepatitis C virus infection aged ≥75 years [J].

Kinoshita, Akiyoshi ;

Koike, Kazuhiko ;

Mizuno, Yusuke ;

Ogata, Itsuro ;

Kobayashi, Yutaro ;

Hasegawa, Kiyoshi ;

Shiraishi, Koichi ;

Yoshida, Hideo ;

Nakata, Ryo ;

Yamada, Norie ;

Yasuda, Kiyomi .

GERIATRICS & GERONTOLOGY INTERNATIONAL, 2020, 20 (06) :578-583

[35] Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older [J].

Yuri Komaki ;

Yoshinori Ozono ;

Kenichi Nakamura ;

Hisayoshi Iwakiri ;

Satoru Hasuike ;

Mitsue Sueta ;

Tadashi Miike ;

Shojiro Yamamoto ;

Hirofumi Uto ;

Kazunori Kusumoto ;

Toshimasa Ochiai ;

Junya Kato ;

Naoto Komada ;

Kazuo Kuroki ;

Toshiharu Eto ;

Masafumi Shigehira ;

Shuichi Hirono ;

Kenji Nagata ;

Hiroshi Kawakami .

BMC Gastroenterology, 22

[36] Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-Registry [J].

Klinker, Hartwig ;

Naumann, Uwe ;

Roessle, Martin ;

Berg, Thomas ;

Bondin, Mark ;

Lohmann, Kristina ;

Koenig, Bettina ;

Zeuzem, Stefan ;

Cornberg, Markus .

LIVER INTERNATIONAL, 2021, 41 (07) :1518-1522

[37] Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naive, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection [J].

Flamm, Steven L. ;

Kort, Jens ;

Marx, Steven E. ;

Strezewski, John ;

Dylla, Douglas E. ;

Bacon, Bruce ;

Curry, Michael P. ;

Tsai, Naoky ;

Wick, Nicole .

ADVANCES IN THERAPY, 2020, 37 (05) :2267-2274

[38] Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment [J].

Yap, Desmond Y. H. ;

Liu, Kevin S. H. ;

Hsu, Yu-Chun ;

Wong, Grace L. H. ;

Tsai, Ming-Chang ;

Chen, Chien-Hung ;

Hsu, Ching-Sheng ;

Hui, Yee Tak ;

Li, Michael K. K. ;

Liu, Chen-Hua ;

Kan, Yee-Man ;

Yu, Ming-Lung ;

Yuen, Man-Fung .

CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) :554-561

[39] Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy [J].

Grebely, Jason ;

Dore, Gregory J. ;

Alami, Negar N. ;

Conway, Brian ;

Dillon, John F. ;

Gschwantler, Michael ;

Felizarta, Franco ;

Hezode, Christophe ;

Tomasiewicz, Krzysztof ;

Fredrick, Linda M. ;

Dumas, Emily O. ;

Mensa, Federico J. .

INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 66 :73-79

[40] Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection [J].

Ng, Teresa, I ;

Pilot-Matias, Tami ;

Tripathi, Rakesh ;

Schnell, Gretja ;

Krishnan, Preethi ;

Reisch, Thomas ;

Beyer, Jill ;

Dekhtyar, Tatyana ;

Irvin, Michelle ;

Lu, Liangjun ;

Asatryan, Armen ;

Campbell, Andrew ;

Yao, Betty ;

Lovell, Sandra ;

Mensa, Federico ;

Lawitz, Eric J. ;

Kort, Jens ;

Collins, Christine .

VIRUSES-BASEL, 2018, 10 (09)

← 1 2 3 4 5 →